Italy vs Turkey: Prevalence of current tobacco use, females
Prevalence of current tobacco use, females over time
- Italy
- Turkey
How they compare
Turkey currently reports 20.2% against 19.3% in Italy, a difference of 0.9%.
The two have swapped places 1 time across 9 shared years of data; in 2000 it was Italy ahead.
Italy ranks 35th and Turkey ranks 32nd of 166 countries.
Across the 3 decades both report, Italy averaged higher in 2 and Turkey in 1.
Head to head by decade
| Decade | Italy | Turkey | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 19.1% | 15.5% | 3.6% | Italy |
| 2010s | 19.1% | 17.4% | 1.8% | Italy |
| 2020s | 19.3% | 19.7% | 0.4% | Turkey |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of current tobacco use, females, Italy or Turkey?
- Turkey, at 20.2% against 19.3% in Italy as of 2024.
- What is the difference in prevalence of current tobacco use, females between Italy and Turkey?
- 0.9%, with Turkey ahead.
- How many years of comparable data are there for Italy and Turkey?
- 9 years are reported by both, from 2000 to 2024.
- How do Italy and Turkey rank globally for prevalence of current tobacco use, females?
- Italy ranks 35th and Turkey ranks 32nd of 166 countries.
- Where does this data come from?
- Global Health Observatory Data Repository, World Health Organization (WHO), published as Prevalence of current tobacco use, females (% of female adults). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of the female population ages 15 years and over who currently use any tobacco product (smoked and/or smokeless tobacco) on a daily or non-daily basis. Tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and all forms of smokeless (oral and nasal) tobacco. Tobacco products exclude e-cigarettes (which do not contain tobacco), “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. The rates are age-standardized to the WHO Standard Population.